PALO ALTO, Calif., Aug. 8, 2017 /PRNewswire/-- Varian Medical
Systems (NYSE: VAR) today announced the first cancer patient was
treated using the company's HyperArc™ High Definition
Radiotherapy (HDRT), a new type of radiosurgery treatment, at Sacro
Cuore Don Calabria Cancer Care Center in Negrar-Verona,
Italy. With HyperArc, clinicians
can deliver more compact radiation doses that closely conform to
the size, shape, and location of tumors while sparing more
surrounding healthy tissue.
"HyperArc HDRT allows us to deliver state-of-the-art
radiosurgery to highly complex cases efficiently and with a very
high degree of dose compactness and conformity," said Prof.
Filippo Alongi, director of
Radiation Oncology at Sacro Cuore Don Calabria Cancer Care Center
and associate professor of Radiation Oncology at Brescia University. "The first patient we treated
with HyperArc was a complex case of multiple intracranial
metastases and we were impressed with the quality and efficiency of
the treatment. We now look forward to following the patient
and further using HyperArc to manage the disease."
"We are very excited about this first treatment using HyperArc
as we usher in a new era of precision in radiotherapy and
radiosurgery for cancer patients," said Kolleen Kennedy, president of Varian Oncology
Systems business.
HyperArc is designed to capitalize on the unique capabilities of
Varian's TrueBeam™ and EDGE™ treatment
platforms. HyperArc treatments exploit specific capabilities of the
platforms to deliver more compact radiation doses that can fully
saturate a targeted tumor and "fall off" sharply outside the target
zone, minimizing and, where necessary, even eliminating dose to
specific organs requiring more protection.
The treatment planning for HyperArc is supported by Varian's
Eclipse™ treatment planning software and is 510(k)
pending. HyperArc treatment delivery has received CE mark and FDA
510(k) clearance and is not for sale in all markets.
About Varian Medical Systems
Varian Medical Systems
focuses energy on saving lives and is the world's leading
manufacturer of medical devices and software for treating and
managing cancer. Headquartered in Palo
Alto, California, Varian employs approximately 6,600 people
around the world. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
About Sacro Cuore Don Calabria Cancer Care
Center
Sacro Cuore Don Calabria Cancer Care Center is the
biggest private Cancer Care Center in North-Est of Italy. The
center is focused on radiosurgery and treats more than 1200 cases
per year, 400 of which are SRS, SBRT and extremely hypofractionated
treatments, all by means of TrueBeam® with FFF mode and RapidArc®
technology. In the last two years, the faculty of Sacro Cuore has
published more than 50 articles on Radiation Oncology with an
impact factor more than 200 points. For more information, visit
www.sacrocuoredoncalabria.it/Servizi-di-diagnosi-e-cura/Radioterapia-Oncologica/Presentazione/
Press Contact
Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com
View original
content:http://www.prnewswire.com/news-releases/first-patient-treated-with-varian-hyperarc-high-definition-radiotherapy-300500877.html
SOURCE Varian Medical Systems